Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaoqing Liang
Observed names:
Liang Xiaoqing,
Qingxiao Liang
Institutions:
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Chongqing Medical University
Observed institutions:
Henan University,
Henan University of Technology,
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Chongqing Medical University
ORCID:
0000-0003-1992-9592
Observed ORCID:
0000-0003-1992-9592
OpenAlex ID:
A5046049978
iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction
2025
·
Bicheng Ye
, Jun Fan
, et al.
·
iMeta
·
152
Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: Targeting SLC25A1 to overcome immune resistance
2025
·
Zhang Pengpeng
, Liang Xiaoqing
, et al.
·
Chinese Journal of Cancer Research
·
78
Navigating the immune landscape with plasma cells: A pan‐cancer signature for precision immunotherapy
2024
·
Bicheng Ye
, Aimin Jiang
, et al.
·
BioFactors
·
58
Adeno-Associated Virus Engineering and Load Strategy for Tropism Modification, Immune Evasion and Enhanced Transgene Expression
2024
·
Xun Zhou
, Jingzhou Liu
, et al.
·
International Journal of Nanomedicine
·
34
PDF
Effects of glycyrrhizin on the growth cycle and ATPase activity of PRRSV-2-infected MARC-145 cells
2021
·
Erzhen Duan
, Beibei Zhang
, et al.
·
Research in Veterinary Science
·
7
Bridging the Gap in Immunotherapy Prediction: The AGAE Score as a Pan-Cancer Biomarker for Immune Checkpoint Inhibitor Response
2024
·
Bicheng Ye
, Jun Fan
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Comparison of the Stability and Hepatotoxicity of Gatifloxacin Salts with 8 Different Acids for Injection
2006
·
Xiaoqing Liang
·
Yaoxue jinzhan
Show more works
View as search
Works count:
7
Citation count:
329
H-index:
5
I10-index:
4
Year
Topic
Type